View our Speaker Lineup Here!



Keynote Speakers

Keynote Speaker 1

Lotte Knudsen
Head of IDEA (Innovation & Data Experimentation Advancement) and Chief Scientific Advisor
Novo Nordisk

Keynote Speaker 2

Colette Delawalla
Executive Director
Stand Up for Science

Keynote Speaker 3

Victor Ambros
Professor, Program in Molecular Medicine; Silverman Professor of Natural Sciences
UMass Chan Medical School

Keynote Speaker 4

Bob Coughlin
Managing Director – Life Science and Healthcare
JLL

Tide Talk Speakers

Tide Talk Speakers

Tony Kulesa
Partner
Pillar VC
Beyond LLMs: How Automation and AI are Reshaping Biotech
Beth Porter
Head of Studio Operations
C10 Labs
Beyond LLMs: How Automation and AI are Reshaping Biotech
Michael Retchin
Founder
NewCo
Beyond LLMs: How Automation and AI are Reshaping Biotech
Dan Spellman
Vice President of AI and OCI, Healthcare & Life Sciences
Oracle
Beyond LLMs: How Automation and AI are Reshaping Biotech
Michael Antonov
Chief Executive Officer
Deep Origin
Beyond LLMs: How Automation and AI are Reshaping Biotech
Satish Tadikonda
Sr. Lecturer in Entrepreneurial Management
Harvard Business School
Biotech Lessons from Kendall Square
Vinit Nijhawan
Managing Director
MassVentures
Biotech Lessons from Kendall Square
Chandra Ramanathan
VP & Head of External Innovation, Life Sciences
Danaher Corporation
Biotech Lessons from Kendall Square
Maggie O’Toole
Chief Executive Officer
LabCentral
Biotech Lessons from Kendall Square
Shashi Ramaih
Founder & CEO
SPECCRO
Biotech Lessons from Kendall Square
Jo Viney
CEO, founder
Seismic Therapeutic
Exits in Biotech – IPO vs. Pharma Acquisition
Sam Hall
Co-Founder & Managing Partner
Scion Life Sciences
Exits in Biotech – IPO vs. Pharma Acquisition
Jolyon Martin
Investment Professional
Vie Ventures
Exits in Biotech – IPO vs. Pharma Acquisition
Cristina M.
Director
RA Capital Management
Exits in Biotech – IPO vs. Pharma Acquisition
Nolan Townsend
Chief Executive Officer
Lexeo Therapeutics
Exits in Biotech – IPO vs. Pharma Acquisition
Warren Browne
Founder & CEO
Browne Consulting
Exits in Biotech – IPO vs. Pharma Acquisition
Sarah MacDonald
CEO
Life Science Cares
Global Leadership: Inside and Outside Companies
Aoife Brennan
President and CEO
LSC
Global Leadership: Inside and Outside Companies
Brendon Pires
Manager, Internal Communications & Corporate Responsibility
Alnylam Pharmaceuticals
Global Leadership: Inside and Outside Companies
Yvonne Hao
Secretary of Economic Development
Commonwealth of Massachusetts
How Policy is Shaping the Future of Biotech Innovations and Patient Impact
Angelika Fretzen
Technology Translation Director & COO
Wyss Institute for Biologically Inspired Engineering
How Policy is Shaping the Future of Biotech Innovations and Patient Impact
Jake Becraft
Co-Founder and CEO
Strand Therapeutics
How Policy is Shaping the Future of Biotech Innovations and Patient Impact
Alta Charo
Emerita Professor of Law and Bioethics
University of Wisconsin-Madison
How Policy is Shaping the Future of Biotech Innovations and Patient Impact
Jennifer McNary
Co-Founder
Canary Advisors
How Policy is Shaping the Future of Biotech Innovations and Patient Impact
Ann DeWitt
General Partner
Engine Ventures
In Focus: Women Leading Life Sciences
Luba Greenwood
Chief Executive Officer, Gallop Oncology
Gallop Oncology
In Focus: Women Leading Life Sciences
Sheila Gujrathi
Co-Founder
Biotech CEO Sisterhood
In Focus: Women Leading Life Sciences
Marissa Petit
Director, Business Development
Genentech
In Focus: Women Leading Life Sciences
Abigail Bracha
President
Edity Therapeutics
In Focus: Women Leading Life Sciences
Stephen Linderman
Founder and CEO
Harvard Business School
“Investing in Women’s Health; Why Now, Why Urgently”
Pita Navarro
Co-Founder, Chief Scientific Officer
Evvy
“Investing in Women’s Health; Why Now, Why Urgently”
Liz Powell
Founder
Women’s Health Advocates, G2G
“Investing in Women’s Health; Why Now, Why Urgently”
Elizabeth Bailey
Managing Partner
Foreground Capital
“Investing in Women’s Health; Why Now, Why Urgently”
Michal Preminger
Head of Innovation, East North America
Johnson & Johnson
Navigating a Career Transition into Big Pharma
James Mutamba
Chief Business Officer
Arrakis Therapeutics
Navigating a Career Transition into Big Pharma
Kendra Rose
Senior Vice President
Bayer
Navigating a Career Transition into Big Pharma
Lori Badura
Vice President
Ipsen
Navigating a Career Transition into Big Pharma
Jonathan Lam
Director – Business Development
Genentech
Navigating a Career Transition into Big Pharma
Austin Draycott
Co-Founder
Cloverleaf Bio
Partnering in 2025: What Founders Need To Know
Uli Stilz
Corporate Vice President, R&ED External Innovation Partners, External & Exploratory Innovation (E2I)
Novo Nordisk
Partnering in 2025: What Founders Need To Know
Jonathan McClain
Executive Director
Eli Lilly and Company
Partnering in 2025: What Founders Need To Know
Mary Clare McCorry
External Innovation Ecosystem and Scientific Engagement Lead
Sanofi
Partnering in 2025: What Founders Need To Know
Jennifer Halbleib
Senior Director, Pharma Partnering
Genentech
Partnering in 2025: What Founders Need To Know
Lane Weaver
Director of Business Development
Genentech
Partnering in 2025: What Founders Need To Know
Catharine Smith
Executive Director
The Termeer Foundation
Patient Impact in Biotechnology
Mike Curtis
President and CEO
eGenesis, Inc.
Patient Impact in Biotechnology
Rohita Sharma, PhD.
Senior Director, Global Strategic Alliances – Patient Experience, Medical Affairs
Alexion Pharmaceuticals, Inc.
Patient Impact in Biotechnology
Frédéric Sattler
Senior Vice President, Head of Commercial Americas – Science and Laboratory Solutions
Merck Group
Patient Impact in Biotechnology
Dominique Verhelle
Co-founder, President and CEO
NextRNA Therapeutics
Raising a Round in 2025: Advice from the Frontlines
Michael Schrader
Co-founder and CEO
Stealth Startup
Raising a Round in 2025: Advice from the Frontlines
Shinichiro Fuse
Partner/Managing Director
TPG
Raising a Round in 2025: Advice from the Frontlines
Lisa Huang
SVP, CSO Partner Team
Curie.Bio
Raising a Round in 2025: Advice from the Frontlines
Nirmesh Patel
Investor
Amino Collective
Raising a Round in 2025: Advice from the Frontlines
John Cumbers
Founder and CEO
SynBioBeta
Sustainability: Nature’s Call to Biotechnology
Pamela Silver
Professor of Systems Biology
Harvard Medical School
Sustainability: Nature’s Call to Biotechnology
Ashley Beckwith
Board Member
Foray Bioscience
Sustainability: Nature’s Call to Biotechnology
Ajikumar Parayil
Founder and CEO
Manus
Sustainability: Nature’s Call to Biotechnology
Kit McDonnell
Head of Ecosystem
Superorganism
Sustainability: Nature’s Call to Biotechnology

2025 Announced Content


”